Mahamaya Lifesciences Limited (BOM:544611)
India · Delayed Price · Currency is INR 166.50
-3.50 (-2.06%)
At close: May 25, 2026
Mahamaya Lifesciences Revenue
In the fiscal year ending March 31, 2026, Mahamaya Lifesciences had annual revenue of 3.30B INR with 24.90% growth. Mahamaya Lifesciences had revenue of 834.84M in the quarter ending March 31, 2026, with 41.52% growth.
Revenue
3.30B
Revenue Growth
+24.90%
P/S Ratio
1.18
Revenue / Employee
42.31M
Employees
78
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.30B | 657.97M | 24.90% |
| Mar 31, 2025 | 2.64B | 1.03B | 63.54% |
| Mar 31, 2024 | 1.62B | 244.50M | 17.83% |
| Mar 31, 2023 | 1.37B | 472.02M | 52.49% |
| Mar 31, 2022 | 899.19M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Best Agrolife | 13.75B |
| Excel Industries | 11.22B |
| Khaitan Chemicals and Fertilizers | 9.69B |
| Rama Phosphates | 8.94B |
| Aries Agro | 6.88B |
| Advance Agrolife | 6.42B |
| Shivalik Rasayan | 3.32B |
| Anya Polytech & Fertilizers | 1.59B |